Heterotrimeric GTP-binding proteins (G protein) are known to participate in the transduction of signals from ligand activated receptors to effector molecules to elicit cellular responses. Sustained activation of cAMP-G protein signaling system by agonist results in desensitization of the pathway at receptor levels, however it is not clear whether such receptor responses induce other changes in post-receptor signaling path that are associated with maintenance of AMP levels, i.e. cAMP-forming adenylate cyclase (AC), cAMP-degrading cyclic nucleotide phosphodiesterase (PDE) and cAMP-dependent protein kinase (PKA). Experiments were performed to determine the expression of AC, PDE, and PKA isoforms in SH-SY5Y neuroblastoma cells, in which cAMP system was activated by expressing a constitutively activated mutant of stimulatory G protein (Q227L Gsα). Expression of ACI mRNA was increased, but levels of ACVIII and ACIX mRNA were decreased. All of the 4 expressed isoforms of PDE (PDE1C, PDE2, PDE 4A, and PDE4B) were increased in mRNA expression; the levels of PKA RIα, RIβ, and RIIβ were increased moderately, however, those of RIIα and Cα were increased remarkably. The activities of AC, PDE and PKA were also increased in the SH-SY5Y cells expressing Q227L Gsα. The similar changes in expression and activity of AC, PDE and PKA were observed in the SH-SY5Y cells treated with dbcAMP for 6 days. Consequently, it is concluded that the cAMP system adapts at the post-receptor level to a sustained activation of the system by differential expression of the isoforms of AC, PDE, and PKA in SH-SY5Y neuroblastoma. We also showed that an increase in cellular cAMP concentration might mediate the observed changes in the cAMP system.
Introduction
Signal transducing heterotrimeric GTP-binding proteins (G protein) relay signals from activated receptors to intracellular effectors to elicit cellular responses (Gilman, 1987) . Binding of signaling molecules such as hormones and neurotransmitters to the receptors makes the receptor undergo conformational change. This conformational change leads to activation of G proteins by promoting the exchange of GDP for GTP on the Gα subunit and finally the dissociation of Gα-GTP from its Gβγ dimer (Bourne et al., 1990) . Both the dissociated Gα-GTP and Gβγ subunits are able to mediate physiological responses by interacting with numerous effectors, including adenylate cyclase, phospholipases, phosphodiesterases, protein kinases, and ion channels (Neer, 1995) . The G protein signal is terminated as the GTP on the Gα subunit is hydrolyzed by intrinsic GTPase which is activated by the regulator of G protein-signaling (RGS) family (Zheng et al., 1999) .
The cAMP system is one of the most intensively studied G protein signaling systems. Many extracellular signals including epinephrine and acetylcholine bind to and activate their seven transmembrane receptors, which couple to stimulatory G proteins (Gsα) or inhibitory G proteins to regulate adenylate cyclase (AC, EC 4.6.1.1.) activity. Activated AC catalyses the formation of cAMP, the key regulator of cAMP system, from ATP. However, the cellular concentration of cAMP is also regulated by cyclic nucleotide phosphodiesterases (PDE, EC 3.1.4.17.) , which degrade cAMP into adenosine 5'-phosphate. An increase in cAMP concentration results in an activation of cAMP dependent protein kinase (PKA, EC 2.7.10.-) as well as ion channels and PKA, in turn, phosphorylates target proteins in order to regulate various metabolism and gene expression, resulting in numerous cellular responses, including proliferation, differentiation, and formation of memory.
When the cAMP signaling system is activated continuously by agonists, the desensitization of the pathway is induced at the receptor level by various mechanisms such as receptor phosphorylation, uncoupling of receptor and G proteins, down-regulation of the receptors (Ferguson and Caron, 1998) . Sustained activation of cAMP system is also achieved, without activation of receptors, by expression of constitutively activated mutants of stimulatory G protein (Gsα) , and by treatment with forskolin or various cAMP analogues. Such sustained activation of cAMP system can influence the cAMP-forming AC, cAMP-degrading PDE and cAMP-binding PKA activity. Therefore, it is quite possible that the adaptation of cAMP system to the sustained activation can induce the downstream effectors such as AC, PDE, and PKA. However, the adaptation of AC, PDE, and PKA expression to a sustained activation of cAMP signaling system has not been clearly recognized.
At least nine genes for mammalian AC have been cloned, and each isoform seems to have different kinetic and regulatory properties, including the response to calcium ions, beta gamma subunits of the G protein, and protein kinase C (Sunahara et al., 1996) . In mammals, PDE are encoded by at least 19 different genes, and each PDE gene contains several distinct transcriptional units that give rise to proteins with subtle structural differences, bringing the number of the PDE proteins close to 50 (Conti and Jin, 2000) . Each PDE isoform seems to have different kinetic properties such as substrate specificity and it responds differentially to diverse regulators such as calcium/calmodulin and cyclic GMP. In addition, the expression of PDE isoforms varies in different tissues (Beavo, 1995) . PKA is composed of distinct catalytic (C) and regulatory (R) subunits, and the holoenzyme contains two C subunits bound to homo-or heterodimers of R subunits. At present, 4 different R subunits and three different C subunits have been identified as separate gene products (Scott, 1991) . The isoform multiplicity of AC, PDE and PKA, is suggested to play an important role in the regulation of the cAMP signaling system by intracellular targeting, crosstalk between a wide variety of other signaling systems, and flux-controlled sensitivity (Houslay and Milligan, 1997) .
The present experiment was performed to examine how cAMP signaling system adapts at post-receptor levels to a sustained activation of cAMP system. The expression levels of isoforms of AC, PDE, and PKA were analyzed in SH-SY5Y neuroblastoma cells of which cAMP system was activated by expressing a constitutively activated mutant of Gsα (Q227L Gsα) (Graziano and Gilman, 1989) . We found that the expression of AC, PDE, and PKA isoforms were changed differentially to a sustained activation of cAMP system resulting in adaptation at the post-receptor level.
Materials and Method

Materials
Materials were obtained as follows: isoproterenol, bovine serum albumin (BSA), Ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), N-(2-hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid) (HEPES), and 3-isobutyl-1-methylxanthine (IBMX) were purchased from Sigma Chemicals; agarose, reverse transcriptase (Superscript II RNase H(−) Reverse transcriptase) were from GIBCO BRL; Taq polymerase was from TaKaRa; HA antibody against hemagglutinin peptide, GTP, FuGENE 6 Transfection Reagent, phosphocreatine, and creatine phosphokinase were from Roche Diagnostics. All other reagents were of analytical grade.
Cell culture
SH-SY5Y human neuroblastoma cells (CRL-2266) were purchased from American Type Culture Collection, and cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, 100 IU/ml penicillin, and 50 µg/ml streptomycin in a humidified atmosphere containing 5% CO 2 in air at 37 o C.
Establishment of SH-SY5Y cells expressing Q227L Gsα
A constitutively activated mutant of Gsα, Q227L Gsα containing hemagglutinin (HA) epitope was kindly provided from Dr. H. Bourne (University of California San Francisco; Levis and Bourne, 1992) . The gene was subcloned in pcDNA3 vector (Invitrogen), and the plasmid was transfected into SH-SY5Y neuroblastoma cells using FuGENE 6 Transfection Reagent. Transfected cells were grown in the medium containing 500 µg/ml G418. The clones expressing the mutant Gsα were selected by analyzing mRNA expression with reverse transcription-polymerase chain reaction (RT-PCR) using primers specific for HA tag region of Q227L Gsα. The primers used for amplifying Gsα were as follows; for transfected Q227L Gsα 5'-GACGTGCCGGATTACGCGTCC and 5'-ATGA-AGTACTTGGCCCGG, for total Gsα 5'-GCTGGAGAG-TCTGGCAAAAGCACC and 5'-ATGAAGTACTTGGCC-CGG. The expression of the mutant protein was also analyzed by Western blot using anti-HA antibody for detection of HA tag region of Q227L Gsα or RM antibody for detection of both the endogenous and exogenous Gsα protein as described (Yang et al., 1999) .
RNA preparation and semi-quantitative RT-PCR
The total RNA was isolated from the harvested cells using acid guanidinium thiocyanate-phenol-chloroform extraction (Chomczynski and Sacchi, 1987) . To analyze the relative amount of mRNA, a series of four mixtures was made by mixing the RNA from the control and the test sample in varying ratios, so that each reaction tube has the same total amount of RNA in a constant volume (Nicoletti and Sassy-Prigent, 1996) . RT-PCR was performed to analyze the mRNA expression of AC and PDE isoforms following the procedures described previously (Cho et al., 2000a; Cho et al., 2000b) . Analysis of PKA isoform expression was performed in the similar way to that of AC and PDE, and the primers used for amplifying PKA isoforms were as follows; for RIα 5'-AGGCAAAACAGATTCAG and 5'-CTCCTTCCCCAAC-ACTG, for RIβ 5'-GAAGGTGATTCCCA AGGACTACAA and 5'-TCCCGGTCGATCCCCCAGAG, for RIIα 5'-CG-ACGCCAAAGGGGACAG and 5'-GGGGCACAGACTC-AATAAATG, for RIIβ 5'-CTGAACGCCTGAAAGTAGT-AG and 5'-GCAGTGGGTTCAACAATATCC, for Cα 5'-AGTCCCGCTCAGAACACAG and 5'-GATAATCTCAG-GGGCCAGG, for Cβ 5'-TAATGCCCGGACTTGAAC and 5'-TCTGCCTTTAACTCTTT, for Cγ 5'-TACGCCGACCA-GCCCATCCAG and 5'-AACCACAGGGGCACAAGCACA.
The amplified DNA products were separated on an agarose gel containing ethidium bromide, and the DNA band density was measured using a gel documentation system and the NIH Image J software. The amount of mRNA was calculated from a linear regression curve made of the measured density, and it was expressed as fold change relative to the vector-transfected control.
Western blot analysis
The expression of Gsα was analyzed by Western blot following the method described previously (Yang et al., 1998) . The antibody against hemagglutinin peptide HA was used to detect HA-tagged mutant Gsα protein, while RM antibody raised against carboxy terminal peptide of Gsα was used to detect the total Gsα proteins, endogenous and transfected proteins.
Measurement of cAMP accumulation
From a 24-well plate containing the SH-SY5Y neuroblastoma cells, the culture medium was removed and then cells were incubated in 500 µl of serum-free Dulbecco's modified Eagles medium containing 100 mM IBMX with or without isoproterenol for 30 min at 37°C. The treatment was terminated by aspiration of medium and by immediate addition of 2.5 M perchloric acid, and the acid extracts were frozen at -20°C until assay (Brown et al., 1971) . After the acid extract was neutralized with 4.2 M KOH, cAMP levels were determined by competitive binding with [ 3 H]cAMP to the cAMP binding protein, which was prepared by expressing the regulatory subunit RIα of cAMP dependent protein kinase in E. coli. Production of cAMP was normalized to the amount of acid-insoluble protein.
Determination of enzyme activities AC
SH-SY5Y neuroblastoma cells were harvested and homogenized in ice-cold buffer containing 0.25 M sucrose, 10 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , and 2 mM EGTA.
Homogenates were centrifuged at 20,000 g at 4°C for 20 min. Pellets were rehomogenized and washed twice with the above buffers, and resuspended in 10 mM TrisHCl and 10 mM MgCl 2 , pH 7.4. The AC assay was carried out with fresh membranes stored in liquid nitrogen following the procedures described by Ammer and Schulz (Ammer and Schulz, 1997) with some modification. AC activity was determined in a reaction mixture (100 µl) containing 40 mM Tris-HCl, pH 7.4, 0.2 mM EGTA, 100 mM NaCl, 10 mM MgCl 2 , 0.5 mM ATP, 5 µg/ml phosphocreatine, 5 IU/ml creatine phosphokinase, 10 µM GTP, and 0.5 mM IBMX. Reactions were started by the addition of 15 µg of membrane protein, allowed to continue for 10 min at 30°C, and were stopped with 2.5 M perchloric acid. The amount of cAMP generated was determined by cAMP binding assay (Brown et al., 1971) .
PDE
PDE activity was determined by measuring the remaining cAMP in the assay mixture after the enzyme reaction. The reaction mixture was composed of 3 mM MgCl 2 , 60 pmol cold cAMP, 1 mM 5'-AMP, 50 mM TrisHCl, pH 7.4 and cytosolic protein (7-15 µg) in a final volume of 200 µl. The reaction was allowed for 15 min at 37°C, and was stopped with 2.0 M perchloric acid. The amount of remaining cAMP was determined by cAMP binding assay.
PKA
PKA activity was assayed as described previously (Yang et al., 1999) . In brief, 10 µl of substrate cocktail containing 500 µM Kemptide and 10 µM cAMP, 10 µl of inhibitor cocktail containing 20 µM PKC inhibitor peptide and 20 µM Compound R24571, and 10 µl of tissue homogenate were added in order. Then the reaction was started by adding 10 µl of the mixture containing 0.5 mM ATP, 75 mM MgCl 2 and 10 µCi of [γ-32 P]ATP (3000 Ci/mmol), and the mixture were incubated for 10 minutes at 30 o C. After incubation, 25 µl of the mixture was blotted on the P81 paper square, and the paper was washed once with 0.75% phosphoric acid. The assay square was transferred to a scintillation vial containing 5 ml scintillation cocktail, and its radioactivity was counted in a scintillation counter (Model Tri-Carb 1600 CA, Packard Instrument Company).
Statistical analysis
Results were analyzed using the two-tailed paired t-test, and a probability level of 0.05 or smaller was used for statistical significance. Results were expressed as the mean ± standard deviation (SD). All experiments were repeated at least three times in duplicate or triplicate. Figure 1 . Expression of Q227L Gsα in SH-SY5Y neuroblastoma cells. Expression of Q227L Gsα mRNA (A), total Gsα mRNA (B), Q227L Gsα protein (C) and total Gsα protein (D). Total RNA was prepared and reverse transcribed using oligo-dT primer, and resulting cDNA was amplified by PCR using primers specific for Q227L Gsα mRNA (A) or primers specific for total Gsα mRNA (B). The expression of the Gsα protein was analyzed by Western blots using an antibody detecting HA tag in the Q227L Gsα protein (C), or RM antibody detecting all forms of Gsα protein (D). The total RNA was isolated from the cells expressing Q227L Gsα or cells treated with dbcAMP for 6 days using acid guanidinium thiocyanatephenol-chloroform extraction. Series of four mixtures were prepared by mixing the RNA with the control and the test sample in varying ratios, so that each reaction tube has the same total amount of RNA in a constant volume to measure the relative amount of mRNA. Semi-quantitative RT-PCR was performed using AC isoform-specific primer sets. The amount of mRNA was calculated from a linear regression curve made from measured density. Values presented are the mRNA amounts expressed as a fold of the mRNA of the vector transfected controls, and are the mean ± standard deviation of at least 3 independent experiments. All the data presented displayed statistically significant difference from the control group (p < 0.05, paired t-test, two-tailed)
Results
Expression of constitutively activated Q227L Gsα
SH-SY5Y neuroblastoma cells transfected with Q227L Gsα were grown in the presence of G418, and then clones expressing mRNA of Q227L Gsα were selected by RT-PCR analysis of mRNA containing HA sequence. Most of the clones expressed Q227L Gsα mRNA containing HA tag sequence, in contrast to the vector-transfected control that did not show the expression ( Figure  1A ). The segment of wild type Gsα was amplified in both the vector control and mutant expressing cells ( Figure 1B) . The expression of Q227L Gsα protein of the selected clones was further confirmed by Western blot probed using anti-HA antibody ( Figure 1C) , which indicated that the mutant tagged proteins were expressed. Western blot analysis using RM antibody, which detected both the wild and mutant types of the protein, showed about 50% increase in the total immunoreactivity in the selected clones ( Figure 1D ). The increase in the immunoreactivity was observed in both the long forms and short forms of Gsα together. Two clones were selected and used for further analysis in this experiment.
Expression of AC, PDE, and PKA isoform mRNAs
In SH-SY5Y cells, ACI, ACVIII, and ACIX mRNAs, among 9 AC isoforms, were expressed enough for quantitative RT-PCR analysis. In the Q227L Gsα-expressing SH-SY5Y neuroblastoma cells, the expression of ACI increased to 178%, but that of ACVIII and ACIX was decreased respectively to 44% and 66% of the vector transfected control cells. When SH-SY5Y neuroblastoma cells were treated with dbcAMP for 6 days, the expression of AC isoforms changed similarly, that is, ACI increased more prominently to 551% and ACVIII and ACIX decreased to 21% and 56% of the untreated control, respectively (Figure 2) .
In SH-SY5Y neuroblastoma cells, PDE 1C, 2, 4A, and 4B were expressed enough amount for analysis by the RT-PCR method. All of the 4 PDE isoform increased in mRNAs expression significantly; PDE1C to 328%, PDE2 to 207%, PDE 4A to 390%, and PDE4B to 272%. The similar increasing pattern of the PDE isoform expression was observed in the SH-SY5Y neuroblastoma cells treated with dbcAMP for 6 days. The expression of PDE1C increases to 388%, PDE2 to 539%, PDE4A to 683%, and PDE4B to 493% respectively in the cells treated with dbcAMP for 6 days ( Figure 3) .
All of the 4 isoforms of PKA regulatory subunit were expressed in SH-SY5Y neuroblastoma cells, but Cα subunit was the only isoform expressed in the cells. Although the expression levels of the PKA regulatory subunits such as RIα, RIβ and RIIβ were increased in the range of 160% to 187%, that of RIIα was increased most prominently to 9.9-fold compared the control. The expression of Cα was also remarkably increased to 12-fold to the vector transfected control. Treatment of the neuroblastoma cells with dbcAMP for 6 days also resulted in the increase of all PKA subunit isoforms expression. The expression of RIα was increased to 270%, RIβ to 621%, RIIα to 244%, RIIβ to 436%, and Cα to 540% of the untreated control (Figure 4) .
Activity of AC, PDE and PKA
To determine the effects of the changes in the mRNA expression of AC, PDE, and PKA, the activity of each enzyme was assayed. Both the basal and forskolinstimulated AC activity was increased in Q227L Gsα transfected SH-SY5Y neuroblastoma cells. The basal AC activity of Q227L Gsα expressing cells increased by 4.1-fold (12.7 ± 0.6 pmol/min mg-protein) from the control (3.1 ± 1.3), and forskolin activated AC activity was also increased from 95.4 ± 8.2 to 134.0 ± 15.2. The PDE activity was also increased about 2.4-fold in Q227L Gsα Table 1 . Activity of AC and PKA in SH-SY5Y neuroblastoma cells expressing Q227L Gsα. The AC activity was determined by the fresh membranes prepared from the Q227L Gsα expressing cells and vector transfected cells, and asterisk (*) indicates AC activity stimulated by forskolin. The PDE activity was determined by measuring remaining cAMP in the assay mixture, and the PKA activity was determined in cell homogenates with Kemptide and [γ- 53.7 ± 2.8 expressing cells (212.8 ± 29.8 pmol/min mg-protein) compared the control (89.3 ± 20.2). The activity of PKA was increased about 3.5-fold from the vector-transfected control (from 14.4 ± 0.9 pmol/min mg-protein to 50.5 ± 2.6) ( Table 1) .
The similar changes in the activities of AC and PKA were also observed in the neuroblastoma cells treated with dbcAMP for 6 days ( Table 1 ). The basal (17.2 ± 3.5 pmol/min mg-protein) and forskolin stimulated (182 ± 12.1) AC activity increased more in dbcAMP-treated cells than Q227L Gsα expressing cells (Table 1) .
cAMP response
To study the consequence of the changes in the mRNA and protein expression of AC and PDE, we analyzed the cellular cAMP response. The basal cAMP level was increased from 8.6 ± 0.3 pmol/mg protein to 71.6 ± 3.3 pmol/mg protein in Q227L Gsα transfected SH-SY5Y cells, and the cAMP response to isoproterenol stimulation was also increased from 54.0 ± 4.9 to 121 ± 5.6 pmol/mg protein. These data showed that both the basal and isoproterenol-stimulated accumulation of cAMP increased in the Q227L Gsα expressing cells. Similar increases in cAMP response were observed in the SH-SY5Y neuroblastoma cells treated with dbcAMP for 6 days. The cAMP level was 72.6 ± 6.3 pmol/mg protein at basal and 161 ± 7.1 pmol/mg protein at stimulated state (Table 2) .
Discussion
This study was performed to examine how cAMP signaling system adapts to a sustained activation of cAMP system at post-receptor levels, and it demonstrated that cAMP system adapts to its sustained activation, by differential changes of isoform expression of AC, PDE, and PKA isoforms in SH-SY5Y neuroblastoma cells expressing Q227L Gsα.
Among the AC isoforms analyzed in this study, expression of ACI increased while expression of ACVII and ACIX decreased. The change in mRNA expression resulted in the increase of forskolin-stimulated activity by 1.4-fold in Q227L Gsα expressing SH-SY5Y neuroblastoma cells. This result indicates that increase in AC activity is a net result of increase in ACI and concomitant decrease in ACVIII and ACIX. Besides, each AC isoform is different in their kinetic and regulatory properties (Simonds, 1999) . The activity of ACI is inhibited by inhibitory G protein alpha subunit and beta-gamma subunit complex of G protein, but it is activated by calcium/ calmodulin complex and protein kinase C. The activity of ACVIII is also activated by calcium/calmodulin complex while the activity of ACIX is inhibited by calcium ions. Thus, increase in the expression of ACI isoform in SH-SY5Y neuroblastoma cells following expression of Q227L Gsα may also result in the increase of the calcium sensitivity and inhibition by G proteins of cAMP signaling system. Similar to AC isoforms, each PDE isoform has different kinetic and regulatory properties. PDE1 family is a calcium/calmodulin dependent enzyme, and has a substrate preference for cGMP. PDE2 is cGMP-stimulated enzyme, which increase PDE2 activity by allosteric mechanism. Thus this isoform is implicated to synchronize the cGMP and cAMP signaling system (Beavo, 1995) . PDE4 family is currently the largest PDE family, and it is widely distributed in many tissues. Because PDE4 isoform is cAMP-specific, it is usually the major enzyme responsible for degradation of cAMP. Therefore, the increased expression of PDE1 observed in the present study might increase calcium/calmodulin dependency of the system, while increased PDE2 expression might increase in cGMP dependency. Increased activity of PDE4A and 4B might contribute to the rapid removal of cAMP formed by AC stimulated by expressed Q227L Gsα. Similar adaptation of two PDE isoforms was reported in the rat Sertoli cell, where the prolonged stimulation of cAMP system by FSH, forskolin, cholera toxin, and N6, O2'-dibutyryl cAMP increased in PDE3 and PDE4 expression (Swinnen et al., 1991) .
The large increase in RIIα and Cα isoform of PKA mRNA expression observed here by expressing Q227L Gsα, also resulted in the increase of the enzyme activity. A high level expression of PKA RI is correlated with active cell growth and transformation, in contrast to high-level expression of RII, which is correlated with growth arrest and differentiation (Cho-Chung, 1990) . Similar changes were obtained by treating cancer cells with 8-Cl-cAMP, a cAMP analogue, which showed a decrease of RIα, an increase of RIIβ, and inhibition of cell growth (Cho-Chung, 1990) .
The mRNA levels do not always reflect the levels of 72.6 ± 6.3 .161 ± 7.1 protein in the examined cells and tissues. Changes in mRNA expression of AC, PDE and PKA isoforms resulted in the changes of respective enzyme activity. The net result of such differential changes in isoform mRNA expression would primarily be determined by the relative contribution of each isoform to the total enzyme activity in a cell or subcellular localization, and by the extent to which individual isoform expression altered. Thus, an analysis of the relative contribution of each isoform to the total activity is essential to understand the functional significance of changes in AC isoform expression. Therefore, better correlation between mRNA and enzyme activity could be obtained by studies such as isoform specific enzyme activity assay following immunoprecipitation with isoform-specific antibody, and the analysis of isoform specific enzyme expression by quantitative Western blot.
We found that the basal and isoproterenol stimulated cAMP response were increased in SH-SY5Y neuroblastoma cells following the expression of Q227L Gsα. The increase in cAMP accumulation may have resulted from an increased AC activity, a decreased PDE activity, or both. The increase in the expression and the activity of both AC and PDE were observed in the present study. Increase in the activity of both cAMP forming AC and cAMP-degrading PDE makes the cell to produce more cAMP and to degrade cAMP more rapidly, so-called high cAMP cycling condition. Such system has high basal AC and PDE activity so that either activation of AC or inhibition of PDE can activate PKA by elevation of cAMP level above the threshold concentration. Before adaptation, the SHSY-5Y cells have low AC and low PDE activity, and the PKA activation threshold is unlikely breached by PDE inhibition in such cells. Thus, in low cAMP cycling condition, AC activation dominates as the means for triggering responses, and it takes longer time to achieve maximum cAMP responses (Houslay and Milligan, 1997) . Thus, SH-SY5Y cells seem to have adapted to the expression of Q227L Gsα from low cAMP cycling condition to high cycling condition. This adaptation demonstrates that the regulatory properties of the cAMP system can be regulated by differential expression of the isoforms of AC and PDE. Such changes in cAMP system may result in the changes of cellular response induced by many biological signals that act through or cross talk with cAMP systems.
In order to examine the mechanism for the differential expression of the isoforms of AC, PDE and PKA induced by expression of Q227L Gsα in SH-SY5Y neuroblastoma cells, we analyzed the expression of the enzyme isoforms in the cells treated with dbcAMP, a membrane permeable cAMP analogue. Similar patterns of isoform expression, though not the same, were observed in the dbcAMP treated cells and Q227L Gsα expressing SH-SY5Y neuroblastoma cells. This result suggests that the differential expression of the isoforms in Q227L Gsα expressing cells is mediated by an increase in intracellular cAMP. Greater increase of AC mRNA and activity in the dbcAMP treated cells than Q227L Gsα expressing cells might reflect the shorter duration of cAMP system activation than Q227L Gsα expressing cells.
Mutant Q227L Gsα differs from the wild type protein in the substitution of Leu for Gln227, respectively. The rate constant for hydrolysis of GTP by Q227L Gsα is roughly 100-fold slower than that of wild type Gsα. This reduction in the rate of hydrolysis of GTP results in significant fractional occupancy of this protein by GTP in the presence of the nucleotide, and causes constitutive activation of the protein (Graziano and Gilman, 1989) . Thus this Q227L Gsα is widely used to activate cAMP signaling system in various tissues (Schutzer et al., 2000) . The cAMP system was found in this study to induce adaptive response to the continuous activation caused by expression of Q227L Gsα by differential expression of isoforms of AC, PDE, and PKA in SH-SY5Y neuroblastoma cells.
In conclusion, we have shown that cAMP system adapts to a sustained activation of the system, by differential expression of the isoforms of AC, PDE, and PKA at mRNA and by changing enzyme activity in SH-SY5Y neuroblastoma cells expressing Q227L Gsα. We have also shown that an increase in cellular cAMP concentration is involved in this adaptation process. The adaptation of cAMP system is suggested to change the regulatory properties of the system so that it may change many signaling system acting through the cAMP system to modify various cellular responses.
